Body mass index and cancer incidence: the FINRISK study
详细信息 查看全文
- 作者：Xin Song (1) (2)
Eero Pukkala (3) (4)
Tadeusz Dyba (3)
Jaakko Tuomilehto (2) (5) (6)
Vladislav Moltchanov (1) (2)
Satu M?nnist? (2)
Pekka Jousilahti (2)
Qing Qiao (1) (7) - 关键词：Body mass index ; Cancer incidence
- 刊名：European Journal of Epidemiology
- 出版年：2014
- 出版时间：July 2014
- 年：2014
- 卷：29
- 期：7
- 页码：477-487
- 全文大小：1,092 KB
- 参考文献：1. World Health Organisation. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee WHO Technical Report Series. WHO: Geneva; 1995.
2. Ford ES. Body mass index and colon cancer in a national sample of adult US men and women. Am J Epidemiol. 1999;150:390-. CrossRef
3. Rapp K, Schroeder J, Klenk J, Stoehr S, Ulmer H, Concin H, et al. Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer. 2005;93:1062-. CrossRef
4. Pischon T, Lahmann PH, Boeing H, Friedenreich C, Norat T, Tjonneland A, et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2006;98:920-1. CrossRef
5. Larsson SC, Rutegard J, Bergkvist L, Wolk A. Physical activity, obesity, and risk of colon and rectal cancer in a cohort of Swedish men. Eur J Cancer. 2006;42:2590-. CrossRef
6. Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF Jr. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control. 2006;17:901-. CrossRef
7. Bassett JK, Severi G, English DR, Baglietto L, Krishnan K, Hopper JL, et al. Body size, weight change, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev. 2010;19:2978-6. CrossRef
8. Michaud DS, Giovannucci E, Willett WC, Colditz GA, Stampfer MJ, Fuchs CS. Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA. 2001;286:921-. ma.286.8.921" target="_blank" title="It opens in new window">CrossRef
9. Patel AV, Rodriguez C, Bernstein L, Chao A, Thun MJ, Calle EE. Obesity, recreational physical activity, and risk of pancreatic cancer in a large US Cohort. Cancer Epidemiol Biomarkers Prev. 2005;14:459-6. CrossRef
10. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D, et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ. 2007;335:1134-4. mj.39367.495995.AE" target="_blank" title="It opens in new window">CrossRef
11. Jiao L, Berrington de Gonzalez A, Hartge P, Pfeiffer RM, Park Y, Freedman DM, et al. Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts. Cancer Causes Control. 2010;21:1305-4. CrossRef
12. Genkinger JM, Spiegelman D, Anderson KE, Bernstein L, van den Brandt PA, Calle EE, et al. A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer. 2011;129:1708-7. CrossRef
13. Bjorge T, Tretli S, Engeland A. Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol. 2004;160:1168-6. CrossRef
14. Luo J, Margolis KL, Adami HO, Lopez AM, Lessin L, Ye W, et al. Body size, weight cycling, and risk of renal cell carcinoma among postmenopausal women: the Women’s Health Initiative (United States). Am J Epidemiol. 2007;166:752-. m137" target="_blank" title="It opens in new window">CrossRef
15. Adams KF, Leitzmann MF, Albanes D, Kipnis V, Moore SC, Schatzkin A, et al. Body size and renal cell cancer incidence in a large US cohort study. Am J Epidemiol. 2008;168:268-7.
16. Kabat GC, Miller AB, Rohan TE. Body mass index and lung cancer risk in women. Epidemiology. 2007;18:607-2. CrossRef
17. Kabat GC, Kim M, Hunt JR, Chlebowski RT, Rohan TE. Body mass index and waist circumference in relation to lung cancer risk in the Women’s Health Initiative. Am J Epidemiol. 2008;168:158-9. CrossRef
18. Smith L, Brinton LA, Spitz MR, Lam TK, Park Y, Hollenbeck AR, et al. Body mass index and risk of lung cancer among never, former, and current smokers. J Natl Cancer Inst. 2012;104:778-9. CrossRef
19. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 1997;6:557-3.
20. Schuurman AG, Goldbohm RA, Dorant E, van den Brandt PA. Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study. Am J Epidemiol. 2000;151:541-. CrossRef
21. Lee IM, Sesso HD, Paffenbarger RS Jr. A prospective cohort study of physical activity and body size in relation to prostate cancer risk (United States). Cancer Causes Control. 2001;12:187-3. CrossRef
22. MacInnis RJ, English DR, Gertig DM, Hopper JL, Giles GG. Body size and composition and prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2003;12:1417-1.
23. Wright ME, Chang SC, Schatzkin A, Albanes D, Kipnis V, Mouw T, et al. Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer. 2007;109:675-4. CrossRef
24. Rodriguez C, Freedland SJ, Deka A, Jacobs EJ, McCullough ML, Patel AV, et al. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev. 2007;16:63-. CrossRef
25. Pischon T, Boeing H, Weikert S, Allen N, Key T, Johnsen NF, et al. Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev. 2008;17:3252-1. CrossRef
26. Terry PD, Miller AB, Rohan TE. Obesity and colorectal cancer risk in women. Gut. 2002;51:191-. CrossRef
27. Bowers K, Albanes D, Limburg P, Pietinen P, Taylor PR, Virtamo J, et al. A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers. Am J Epidemiol. 2006;164:652-4. CrossRef
28. Adams KF, Leitzmann MF, Albanes D, Kipnis V, Mouw T, Hollenbeck A, et al. Body mass and colorectal cancer risk in the NIH-AARP cohort. Am J Epidemiol. 2007;166:36-5. m049" target="_blank" title="It opens in new window">CrossRef
29. Kuchiba A, Morikawa T, Yamauchi M, Imamura Y, Liao X, Chan AT, et al. Body mass index and risk of colorectal cancer according to fatty acid synthase expression in the nurses-health study. J Natl Cancer Inst. 2012;104:415-0. CrossRef
30. Robsahm TE, Tretli S. Height, weight and gastrointestinal cancer: a follow-up study in Norway. Eur J Cancer Prev. 1999;8:105-3. CrossRef
31. Engeland A, Tretli S, Austad G, Bjorge T. Height and body mass index in relation to colorectal and gallbladder cancer in two million Norwegian men and women. Cancer Causes Control. 2005;16:987-6. CrossRef
32. Sjodahl K, Jia C, Vatten L, Nilsen T, Hveem K, Lagergren J. Body mass and physical activity and risk of gastric cancer in a population-based cohort study in Norway. Cancer Epidemiol Biomarkers Prev. 2008;17:135-0. CrossRef
33. Wolk A, Gridley G, Svensson M, Nyren O, McLaughlin JK, Fraumeni JF, et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control. 2001;12:13-1. CrossRef
34. Larsson SC, Wolk A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer. 2007;97:1005-.
35. Koebnick C, Michaud D, Moore SC, Park Y, Hollenbeck A, Ballard-Barbash R, et al. Body mass index, physical activity, and bladder cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev. 2008;17:1214-1. CrossRef
36. Holick CN, Giovannucci EL, Stampfer MJ, Michaud DS. Prospective study of body mass index, height, physical activity and incidence of bladder cancer in US men and women. Int J Cancer. 2007;120:140-. CrossRef
37. Lukanova A, Bjor O, Kaaks R, Lenner P, Lindahl B, Hallmans G, et al. Body mass index and cancer: results from the Northern Sweden Health and Disease Cohort. Int J Cancer. 2006;118:458-6. CrossRef
38. Leitzmann MF, Koebnick C, Danforth KN, Brinton LA, Moore SC, Hollenbeck AR, et al. Body mass index and risk of ovarian cancer. Cancer. 2009;115:812-2. CrossRef
39. Lahmann PH, Cust AE, Friedenreich CM, Schulz M, Lukanova A, Kaaks R, et al. Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2010;126:2404-5.
40. World Cancer Research Fund. Ovarian Cancer 2014 Report. Food, Nutrition, Physical Activity, and the Prevention of Ovarian Cancer. http://www.dietandcancerreport.org/cup/cup_resources.php. June 2013.
41. Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, Manson JE, et al. Dual effects of weight and weight gain on breast cancer risk. JAMA. 1997;278:1407-1. ma.1997.03550170037029" target="_blank" title="It opens in new window">CrossRef
42. van den Brandt PA, Dirx MJ, Ronckers CM, van den Hoogen P, Goldbohm RA. Height, weight weight change, and postmenopausal breast cancer risk: the Netherlands Cohort Study. Cancer Causes Control. 1997;8:39-7. CrossRef
43. van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000;152:514-7. CrossRef
44. Morimoto LM, White E, Chen Z, Chlebowski RT, Hays J, Kuller L, et al. Obesity, body size, and risk of postmenopausal breast cancer: the Women’s Health Initiative (United States). Cancer Causes Control. 2002;13:741-1. CrossRef
45. Jonsson F, Wolk A, Pedersen NL, Lichtenstein P, Terry P, Ahlbom A, et al. Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish Twin Registry. Int J Cancer. 2003;106:594-. CrossRef
46. Lahmann PH, Hoffmann K, Allen N, van Gils CH, Khaw KT, Tehard B, et al. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer. 2004;111:762-1. CrossRef
47. Anderson GL, Neuhouser ML. Obesity and the risk for premenopausal and postmenopausal breast cancer. Cancer Prev Res (Phila). 2012;5:515-1. CrossRef
48. Vartiainen E, Jousilahti P, Alfthan G, Sundvall J, Pietinen P, Puska P. Cardiovascular risk factor changes in Finland, 1972-997. Int J Epidemiol. 2000;29:49-6. CrossRef
49. Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol. 1994;33:365-. CrossRef
50. Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology. 1995;6:356-5. CrossRef
51. Huelsenbeck JP, Hillis DM, Nielsen R. A likelihood-ratio test of monophyly. Syst Biol. 1996;45:546-8. CrossRef
52. Patrick R, Willi S. Multivariable modelling with cubic regression splines: a principled approach. Stata J. 2007;7:45-0.
53. Wood R, Fraser LA, Brewster DH, Garden OJ. Epidemiology of gallbladder cancer and trends in cholecystectomy rates in Scotland, 1968-998. Eur J Cancer. 2003;39:2080-. CrossRef
54. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology. 2003;37:1202-9. CrossRef
55. Qian Y, Fan JG. Obesity, fatty liver and liver cancer. Hepatobiliary Pancreat Dis Int. 2005;4:173-.
56. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51:679-9. CrossRef
57. Dobrian AD, Davies MJ, Schriver SD, Lauterio TJ, Prewitt RL. Oxidative stress in a rat model of obesity-induced hypertension. Hypertension. 2001;37:554-0. CrossRef
58. Hall JE, Crook ED, Jones DW, Wofford MR, Dubbert PM. Mechanisms of obesity-associated cardiovascular and renal disease. Am J Med Sci. 2002;324:127-7. CrossRef
59. Chade AR, Lerman A, Lerman LO. Kidney in early atherosclerosis. Hypertension. 2005;45:1042-. CrossRef
60. de Jong PE, Verhave JC, Pinto-Sietsma SJ, Hillege HL, PREVEND study group. Obesity and target organ damage: the kidney. Int J Obes Relat Metab Disord. 2002;26(Suppl 4):S21-. CrossRef
61. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4:579-1. CrossRef
62. Jenkins PJ, Bustin SA. Evidence for a link between IGF-I and cancer. Eur J Endocrinol. 2004;151(Suppl 1):S17-2. CrossRef
63. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89:2548-6. CrossRef
64. Renehan AG, Roberts DL, Dive C. Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem. 2008;114:71-3. CrossRef
65. Osorio-Costa F, Rocha GZ, Dias MM, Carvalheira JB. Epidemiological and molecular mechanisms aspects linking obesity and cancer. Arq Bras Endocrinol Metabol. 2009;53:213-6. CrossRef
66. Hodge AM, Westerman RA, de Courten MP, Collier GR, Zimmet PZ, Alberti KG. Is leptin sensitivity the link between smoking cessation and weight gain? Int J Obes Relat Metab Disord. 1997;21:50-. CrossRef
67. Ruige JB, Dekker JM, Blum WF, Stehouwer CD, Nijpels G, Mooy J, et al. Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study. Diabetes Care. 1999;22:1097-04. CrossRef
68. Brennan P, McKay J, Moore L, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, et al. Obesity and cancer: mendelian randomization approach utilizing the FTO genotype. Int J Epidemiol. 2009;38:971-. CrossRef
69. Rose DP, Vona-Davis L. Interaction between menopausal status and obesity in affecting breast cancer risk. Maturitas. 2010;66:33-. maturitas.2010.01.019" target="_blank" title="It opens in new window">CrossRef
70. Amadou A, Ferrari P, Muwonge R, Moskal A, Biessy C, Romieu I, et al. Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose-response meta-analysis. Obes Rev. 2013;14:665-8. CrossRef
71. Schoen RE, Tangen CM, Kuller LH, Burke GL, Cushman M, Tracy RP, et al. Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst. 1999;91:1147-4. CrossRef
72. Kelesidis I, Kelesidis T, Mantzoros CS. Adiponectin and cancer: a systematic review. Br J Cancer. 2006;94:1221-. CrossRef
73. Bluher M, Brennan AM, Kelesidis T, Kratzsch J, Fasshauer M, Kralisch S, et al. Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays. Diabetes Care. 2007;30:280-. CrossRef
74. Molarius A, Seidell JC, Sans S, Tuomilehto J, Kuulasmaa K. Educational level, relative body weight, and changes in their association over 10?years: an international perspective from the WHO MONICA Project. Am J Public Health. 2000;90:1260-. CrossRef
75. Rohrmann S, Steinbrecher A, Linseisen J, Hermann S, May A, Luan J, et al. The association of education with long-term weight change in the EPIC-PANACEA cohort. Eur J Clin Nutr. 2012;66:957-3. CrossRef
76. Gonzalez MC, Pastore CA, Orlandi SP, Heymsfield SB. Obesity paradox in cancer: new insights provided by body composition. Am J Clin Nutr. 2014;99:999-005. CrossRef
77. Gonzalez CA, Sala N, Rokkas T. Gastric cancer: epidemiologic aspects. Helicobacter. 2013;18(Suppl 1):34-. CrossRef - 作者单位：Xin Song (1) (2)
Eero Pukkala (3) (4)
Tadeusz Dyba (3)
Jaakko Tuomilehto (2) (5) (6)
Vladislav Moltchanov (1) (2)
Satu M?nnist? (2)
Pekka Jousilahti (2)
Qing Qiao (1) (7)
1. Department of Public Health, Hjelt Institute, University of Helsinki, Mannerheimintie 172, PL41, 00014, Helsinki, Finland
2. Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland
3. Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland
4. School of Health Sciences, University of Tampere, Tampere, Finland
5. Center for Vascular Prevention, Danube University Krems, Krems, Austria
6. King Abdulaziz University, Jeddah, Saudi Arabia
7. R&D AstraZeneca AB, M?lndal, Sweden - ISSN：1573-7284
文摘
The relation between body mass index (BMI) and risk of cancer incidence is controversial. Cancer incidence during 1972-008 in relation to BMI was investigated in a prospective cohort of 54,725 Finns aged 24-4?years and free of cancer at enrollment. Over a mean follow-up of 20.6?years, 8,429 (15.4?%) incident cancers were recorded, 4,208 (49.9?%) from men. Both parametric and nonparametric approaches were used to evaluate the shape of the relationship between BMI and incidence of cancer. BMI had a linear positive association with incidence of cancers of the colon, liver, kidney, bladder and all sites combined in men, and of cancers of the stomach, colon, gallbladder and ovary in women, an inverse association with incidence of cancers of the lung in men and the lung and breast in women, a J-shaped association with incidence of all cancers combined in women. High BMI in women was associated with an increased overall cancer risk in never smokers but a reduced risk in smokers. Elevated BMI was associated with an increased risk of incidence of cancers of certain sites.